Chitin, chitosan, and glycated chitosan regulate immune responses : the novel adjuvants for cancer vaccine
Joint Authors
Hode, Tomas
Chen, Dianjun
Li, Xiaosong
Min, Min
Naylor, Mark
Du, Nan
Nordquist, Robert E.
Gu, Ying
Chen, Wei R.
Source
Clinical and Developmental Immunology
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-03-04
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently.
Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine.
In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development.
American Psychological Association (APA)
Li, Xiaosong& Min, Min& Du, Nan& Gu, Ying& Hode, Tomas& Naylor, Mark…[et al.]. 2013. Chitin, chitosan, and glycated chitosan regulate immune responses : the novel adjuvants for cancer vaccine. Clinical and Developmental Immunology،Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-468093
Modern Language Association (MLA)
Li, Xiaosong…[et al.]. Chitin, chitosan, and glycated chitosan regulate immune responses : the novel adjuvants for cancer vaccine. Clinical and Developmental Immunology No. 2013 (2013), pp.1-8.
https://search.emarefa.net/detail/BIM-468093
American Medical Association (AMA)
Li, Xiaosong& Min, Min& Du, Nan& Gu, Ying& Hode, Tomas& Naylor, Mark…[et al.]. Chitin, chitosan, and glycated chitosan regulate immune responses : the novel adjuvants for cancer vaccine. Clinical and Developmental Immunology. 2013. Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-468093
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-468093